| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/21/2001 | CN1062311C Fused gene of IL-2 derivatives and ANP derivatives, protein products and their application thereof |
| 02/21/2001 | CN1062162C External use ointment for treatment of cutaneous pigmentation |
| 02/20/2001 | US6191282 Derivatives of 5-membered nitrogen containing heterocyclic ring is used as anticarcinogenic agent and anticoagulant |
| 02/20/2001 | US6191269 Selective induction of cell death by delivery of amino-terminal interleukin-1-α pro-piece polypeptide |
| 02/20/2001 | US6191261 Immunoglobulin that preferential binds a growth factor; for the diagnosis and treatment of cell proliferative defects; antiproliferative agents |
| 02/20/2001 | US6191260 Brain-associated inhibitor of tissue-type plasminogen activator |
| 02/20/2001 | US6191257 Natural or recombinant DNA binding proteins as carriers for gene transfer or gene therapy |
| 02/20/2001 | US6191255 Isolated matrix metalloproteinase of given amino acid sequence having the activation capability of pro-matrix metalloproteinase 2; vectors; transformed cells; use in diagnosis of cancer |
| 02/20/2001 | US6191254 Of given amino acid sequences |
| 02/20/2001 | US6191172 Used in drugs and cosmetics |
| 02/20/2001 | US6191169 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states |
| 02/20/2001 | US6191166 Methods and compounds for inhibiting β-amyloid peptide release and/or its synthesis |
| 02/20/2001 | US6191156 Compositions and methods for treating bladder dysfunction |
| 02/20/2001 | US6191139 Antidepressant |
| 02/20/2001 | US6191115 Peptides and polypeptides |
| 02/20/2001 | US6191114 Immunological activity for a peptide of the limulus anti-LPS factor |
| 02/20/2001 | US6191113 Peptide for inhibiting growth of smooth muscle cells |
| 02/20/2001 | US6191112 Human therapeutic uses of BPI protein products |
| 02/20/2001 | US6191110 Promoting wound healing in mammals with peptides |
| 02/20/2001 | US6191109 Methods of treating intestinal ischemia using heparin-binding epidermal growth factor |
| 02/20/2001 | US6191108 RH blood group antigen compositions and methods of use |
| 02/20/2001 | US6191107 Complexes with biodregadable polymers |
| 02/20/2001 | US6191106 Muteins of epidermal growth factor exhibiting enhanced binding at low pH |
| 02/20/2001 | US6191105 Insulin free compositions with insulin-methyl(ethylene glycol)-o-hexanoic acid conjugate and composition with water in oil microemulsion |
| 02/20/2001 | US6191104 Methods of treating graft rejection with the IL-17 receptor |
| 02/20/2001 | US6191103 Inhibitors of protein band iii ligand |
| 02/20/2001 | US6191102 Glucagon like peptide |
| 02/20/2001 | US6190912 Nucleotide sequences coding modulator of cell killing; for the treatment of cell proliferation defects |
| 02/20/2001 | US6190909 TH2-specific gene |
| 02/20/2001 | US6190901 Chicken interleukin-15 and uses thereof |
| 02/20/2001 | US6190897 Nucleotide sequence coding hydrolase; for use in digestion of animal feeds |
| 02/20/2001 | US6190894 Method and compositions for disrupting the epithelial barrier function |
| 02/20/2001 | US6190887 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein |
| 02/20/2001 | US6190884 Transforming host cell with polynucleotide which encodes the growth factor of defined amino acid sequence, and culturing for gene expression |
| 02/20/2001 | US6190881 Polynucleotide; recombinant production; drug screening of bactericides and enzyme inhibitors |
| 02/20/2001 | US6190880 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 02/20/2001 | US6190875 Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe |
| 02/20/2001 | US6190873 Mixing in aqueous medium the sample, a cyclosporin-label conjugate having specific linking groups, and antibodies capable of binding to cyclosporin-label conjugate; and determining presence of complex |
| 02/20/2001 | US6190871 Determining efficacy of monoclonal antibody to neutralize primary isolates by culturing various concentrations of antibody with virus and h9 cells, determining concentration of p24 antigen as indicator of infection, and comparing |
| 02/20/2001 | US6190869 Antisense inhibition of protein kinase C-theta expression |
| 02/20/2001 | US6190866 Selecting bacterial target gene, preparing peptide nucleic acid having region complementary to target, identifying active peptide nucleic acid, contacting bacteria with active compounds, and determining effect on bacteria; bactericides |
| 02/20/2001 | US6190864 HCV genomic sequences for diagnostics and therapeutics |
| 02/20/2001 | US6190863 Immunoglobulin m which recognizes gangioside gm2 which appears on human immunodeficiency virus infected t-cells; viricides; causes complement-mediated cytolysis in humans |
| 02/20/2001 | US6190723 Neutralization of food allergens by thioredoxin |
| 02/20/2001 | US6190663 Human MAP kinase homolog |
| 02/20/2001 | US6190662 Materials and methods relating to the attachment and display of substances on cell surfaces |
| 02/20/2001 | US6190658 Genetically modified manganese superoxide dismutase for treating oxidative damage |
| 02/20/2001 | US6190656 Activating mammalian immune system entails series of il-2 administrations that are effected intermittently over an extended period; each administration of il-2 is sufficient to allow spontaneous dna synthesis; measuring dna synthesis |
| 02/20/2001 | US6190655 Methods of using Flt-3 ligand for exogenous gene transfer |
| 02/20/2001 | US6190640 Administering indium radiolabelled humanized monoclonal antibody or a in radiolabelled binding fragment of a humanized monoclonal antibody which binds to antigen a33 which is presented on surfaces of cells of cancer carcinoma |
| 02/20/2001 | CA2513033A1 Cosmetic use of botulinum toxin for treatment of downturned mouth |
| 02/20/2001 | CA2302629C Estrogen receptor |
| 02/20/2001 | CA2225412C A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component |
| 02/20/2001 | CA2199403C Novel pka-binding proteins and uses thereof |
| 02/20/2001 | CA2197233C Methods of identifying compounds useful for treating autoimmune diseases |
| 02/20/2001 | CA2158991C Adipocyte differentiation inhibiting peptide and adipocyte differentiation inhibiting agent using the peptide as active component thereof |
| 02/20/2001 | CA2125037C Nitrosylation of protein sh groups and amino acid residues as a therapeutic modality |
| 02/20/2001 | CA2110797C Modified sialyl lewis x compounds |
| 02/20/2001 | CA2076749C Vasoactive vasotocin derivatives |
| 02/20/2001 | CA2072658C Use of honey as vaccine |
| 02/20/2001 | CA2060208C Wound healing |
| 02/20/2001 | CA2043536C Tumor cell growth inhibitor |
| 02/20/2001 | CA1341185C Intercellular adhesion molecules and their binding ligands |
| 02/20/2001 | CA1341182C Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 02/15/2001 | WO2001011369A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 02/15/2001 | WO2001011335A2 Antiviral compounds that inhibit viral replication |
| 02/15/2001 | WO2001011085A2 Bdnf polymorphism and association with bipolar disorder |
| 02/15/2001 | WO2001011067A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | WO2001011064A2 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | WO2001011063A2 Gene transfer combination vectors, method for the production and utilization thereof |
| 02/15/2001 | WO2001011050A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 02/15/2001 | WO2001011049A2 Methods and compositions concerning canine interleukin 5 |
| 02/15/2001 | WO2001011048A2 Therapeutic polypeptides and methods for using same |
| 02/15/2001 | WO2001011047A2 Dna sequences isolated from human colonic epithelial cells |
| 02/15/2001 | WO2001011046A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | WO2001011044A1 Tumor antigen |
| 02/15/2001 | WO2001011043A1 Single-chain polypeptides comprising troponin i n-terminal fragments and troponin c |
| 02/15/2001 | WO2001011041A1 MONOMERIC PROTEIN OF THE TGF-β FAMILY |
| 02/15/2001 | WO2001011038A2 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 02/15/2001 | WO2001011031A2 Gene transfer to pancreatic beta cells for prevention of islet dysfunction |
| 02/15/2001 | WO2001011028A1 Glucuronoxylomannan (gxm)-o-acetylhydrolase of cryptococcus neoformans and uses thereof |
| 02/15/2001 | WO2001011023A1 Treatment of inflammatory or malignant disease using dnazymes |
| 02/15/2001 | WO2001011022A1 Mouse g-protein coupled receptor edg3 |
| 02/15/2001 | WO2001011013A2 The interaction of smad6 with hox proteins and uses thereof |
| 02/15/2001 | WO2001011012A2 Human melanoma h11 gene polynucleotides, polypeptides, and methods of use |
| 02/15/2001 | WO2001010912A1 Multiple cytokine-antibody complexes |
| 02/15/2001 | WO2001010907A2 Therapeutic polypeptides and methods for using same |
| 02/15/2001 | WO2001010904A1 Map |
| 02/15/2001 | WO2001010903A2 Proteases and protease inhibitors |
| 02/15/2001 | WO2001010902A2 Nucleoc acids and secreted polypeptides encoded thereby |
| 02/15/2001 | WO2001010901A2 Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 02/15/2001 | WO2001010900A2 Globular assembly of amyloid beta protein and uses thereof |
| 02/15/2001 | WO2001010899A2 Treatment of liver disease and injury with cxc chemokines |
| 02/15/2001 | WO2001010898A2 Compositions and methods for regulating the cell cycle and other cellular processes involving the tgf-beta family |
| 02/15/2001 | WO2001010895A1 Streptogramin derivatives, production thereof and compositions containing the same |
| 02/15/2001 | WO2001010894A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis |
| 02/15/2001 | WO2001010893A2 Il-16 antagonists |
| 02/15/2001 | WO2001010892A2 Peptide antagonists of factor viia |
| 02/15/2001 | WO2001010891A2 Il-16 antagonists |
| 02/15/2001 | WO2001010889A1 Rat-g-protein coupled receptor brs3 |